The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 20, 2018

Filed:

Jan. 26, 2012
Applicants:

Harold David Gunn, Vancouver, CA;

Salim Dhanji, North Vancouver, CA;

Brett Anthony Premack, San Francisco, CA (US);

Michael Tak Huai Chow, Richmond, CA;

Inventors:

Harold David Gunn, Vancouver, CA;

Salim Dhanji, North Vancouver, CA;

Brett Anthony Premack, San Francisco, CA (US);

Michael Tak Huai Chow, Richmond, CA;

Assignee:

Qu Biologics Inc., Burnaby, British Columbia, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/05 (2006.01); A61K 39/00 (2006.01); A61K 39/108 (2006.01); A61K 39/112 (2006.01); A61K 39/085 (2006.01); A61K 39/09 (2006.01); G01N 33/569 (2006.01); A61K 39/095 (2006.01); A61K 39/102 (2006.01); A61K 39/104 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 39/0008 (2013.01); A61K 39/0258 (2013.01); A61K 39/0266 (2013.01); A61K 39/0275 (2013.01); A61K 39/05 (2013.01); A61K 39/085 (2013.01); A61K 39/092 (2013.01); A61K 39/095 (2013.01); A61K 39/102 (2013.01); A61K 39/1045 (2013.01); G01N 33/569 (2013.01); A61K 2039/521 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/542 (2013.01); A61K 2039/545 (2013.01); A61K 2039/58 (2013.01); A61K 2039/585 (2013.01); A61K 2039/70 (2013.01); Y02A 50/474 (2018.01); Y02A 50/478 (2018.01); Y02A 50/482 (2018.01);
Abstract

The invention provides methods of formulating an anti-inflammatory composition for treating inflammatory conditions in a specific organ or tissue. The method involves selecting at least one pathogen that is pathogenic in the specific organ or tissue; producing an antigenic composition comprising antigenic determinants that together are specific for the pathogen; and formulating the antigenic composition for administration as an anti-inflammatory composition capable of eliciting an anti-inflammatory response in the specific organ or tissue. In embodiments of the invention the pathogen may be an endogenous pathogen, such as an endogenous bacterial pathogen. The pathogen may be an exogenous pathogen, such as a bacterial pathogen, viral pathogen, a fungal pathogen, or a helminth pathogen.


Find Patent Forward Citations

Loading…